A strong team with experience and know-how


Dr. Walter von Horstig - Vorstand
Attila Strauss

Attila Stauss

Mr Attila Strauss studied International Trade Management (B.A.) and Information Technology with a focus on IT Security (M.Sc.) in Ingolstadt and Bochum. Before joining the group of companies, Mr Strauss worked for well-known companies in the field of process optimisation. At M1 Kliniken AG he is responsible for the areas of administration, finance, IT and international expansion with a focus on Eastern Europe.

Kilian Brenske - Vorstand
Kilian Brenske

Kilian Brenske

Mr Kilian Brenske studied business administration in Berlin and graduated with a Master of Science in Management and Innovation.

Mr Kilian Brenske has been with the company since 2016 and has been responsible for all major business areas in Germany and abroad during this time. In particular, he built up the medical skin care brand M1 Select, significantly improved the productivity of the sites and most recently led the international expansion. With the addition of Mr. Kilian Brenske to the Management Board, M1 Kliniken AG is underlining its strategic goal of international growth. Mr Brenske will be responsible for national and international expansion, marketing, purchasing and sales.



Uwe Zimdars
Prof. Dr. med. Dirk Hempel
Prof. Dr. Dr. Sabine Meck

Latest news

| Investor News

  • 20th Location outside Germany opened in Bucharest, Romania
  • Break-even expected for foreign locations within the next 12 months
  • Subsidiary established in the USA: Market entry into the world's largest market for beauty medicine expected in 2024

| Investor News

  • Group revenue increases by around 9% to EUR 150.8 million in the first half of 2023 (previous year: EUR 138.7 million)
  • Group EBIT increases by over 60 % to EUR 7.3 million (previous year: EUR 4.5 million)
  • Beauty segment: sales increase of more than 33% to EUR 37.2 million and EBIT margin above 20 % for the first time

M1 Kliniken AG announces figures for the first quarter of 2023. Accordingly, the consolidated group revenue of the M1 Group increased by around 21% to EUR 76.8 million in the first quarter (previous year: EUR 63.5 million).

| Ad-hoc news

The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,500,000 shares of the Company in a maximum total volume of EUR 10,800,000.00 (excluding incidental acquisition costs).